Methylcobalamin and Mesalamine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Methylcobalamin (vitamin b12) and Mesalamine (mesalamine). Common drug interactions include arthralgia among females and pneumonia bacterial among males.
The phase IV clinical study analyzes what interactions people have when they take Methylcobalamin and Mesalamine. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.
What is Methylcobalamin?
Methylcobalamin has active ingredients of vitamin b12. It is often used in vitamin b12 deficiency. eHealthMe is studying from 3,184 Methylcobalamin users. Check the latest studies of Methylcobalamin.
What is Mesalamine?
Mesalamine has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 28,053 Mesalamine users. Check the latest studies of Mesalamine.
27 people who take Methylcobalamin and Mesalamine together, and have interactions are studied.

What are the common drug interactions of Methylcobalamin and Mesalamine, by gender? *:
female:
- Arthralgia (joint pain)
- Fatigue (feeling of tiredness)
- Muscular weakness (muscle weakness)
- Anxiety
- Blood pressure decreased
- Constipation
- Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
- Diarrhoea
- Haematochezia (passage of stools containing blood)
- Haemoglobin decreased
male:
- Pneumonia bacterial (pneumonia associated with bacterial infection)
- Pneumonia
- Loss of consciousness
- Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
- Nightmare (unpleasant dream)
- Pleural effusion (water on the lungs)
- Rales (an abnormal respiratory sound characterized by fine crackles)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Sleep paralysis (waking up and unable to move or speak)
- Superinfection
What are the common drug interactions of Methylcobalamin and Mesalamine, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Pneumonia
- Pneumonia bacterial (pneumonia associated with bacterial infection)
30-39:
- Anxiety
- Heart rate decreased
- Hypotension (abnormally low blood pressure)
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Precancerous skin lesion
- Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
- Surgery
40-49:
- Abdominal abscess (collection of pus in abdomen)
- Appendicitis perforated (perforated appendicitis is a condition in which an inflamed appendix bursts)
- Chronic inflammatory demyelinating polyradiculoneuropathy (long lasting infection of nerves outside brain and spinal cord)
- Nausea (feeling of having an urge to vomit)
- Vomiting
50-59:
- Cold sweat
- Dyspnoea (difficult or laboured respiration)
- Hypoaesthesia (reduced sense of touch or sensation)
- Loss of consciousness
- Nightmare (unpleasant dream)
- Sleep paralysis (waking up and unable to move or speak)
- Tremor (trembling or shaking movements in one or more parts of your body)
60+:
- Arthralgia (joint pain)
- Muscular weakness (muscle weakness)
- Asthenia (weakness)
- Fall
- Fatigue (feeling of tiredness)
- Gait disturbance
- Grip strength decreased
- Mobility decreased (ability to move is reduced)
- Skin infection
- Skin wound
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 33.33%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 9 people, 33.33%
- Abdominal Discomfort: 6 people, 22.22%
- Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 4 people, 14.81%
- Inflammatory Bowel Disease: 2 people, 7.41%
- Depression: 2 people, 7.41%
- Adrenal Insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids): 2 people, 7.41%
* Approximation only. Some reports may have incomplete information.
Do you take Methylcobalamin and Mesalamine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Methylcobalamin (3,184 reports)
- Mesalamine (28,053 reports)
Browse all drug interactions of Methylcobalamin and Mesalamine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Methylcobalamin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Mesalamine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Methylcobalamin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Mesalamine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
- Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on vitamin b12 and mesalamine (the active ingredients of Methylcobalamin and Mesalamine, respectively), and Methylcobalamin and Mesalamine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Amlodipine cause Libido Increased? - 9 seconds ago
- Drug interactions of Cotrim and Pantosin - 9 seconds ago
- Could Lorazepam cause Amyloidosis? - 9 seconds ago
- Drug interactions of Betaderm and Methylprednisolone Sodium Succinate - 13 seconds ago
- Drug interactions of Lotrel and Duragesic-100 - 15 seconds ago
- Could Effexor cause Sinus Disorder? - 22 seconds ago
- Could Levothyroxine Sodium cause Suicidal Ideation? - 23 seconds ago
- Could Tizanidine Hydrochloride cause Fungal Infection? - 28 seconds ago
- Could Levothyroxine Sodium cause Mitral Valve Incompetence? - 29 seconds ago
- Could Levothyroxine Sodium cause Feeling Hot? - 31 seconds ago